| Havrix |
103475 |
004 |
351(a) |
Hepatitis A Vaccine |
Injection |
Intramuscular |
1440ELISA U/ML |
Single-Dose Vial |
1995/02/22
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Human Albumin Grifols |
103352 |
001 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
12.5G/50ML |
Single-Dose Vial |
1995/02/17
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Human Albumin Grifols |
103352 |
003 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
10G/50ML |
Single-Dose Vial |
1995/02/17
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Reopro |
103575 |
001 |
351(a) |
abciximab |
Injection |
Intravenous |
2MG/ML |
Single-Dose Vial |
1994/12/22
|
Janssen Biotech, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
|
103569 |
001 |
351(a) |
Plague Vaccine |
Injection |
Intramuscular |
2BIL. CELL/ML |
Single-Dose Vial |
1994/10/05
|
Greer Laboratories, Inc. |
Disc |
Licensed |
|
N/A |
| Humegon |
020328 |
001 |
351(a) |
menotropins |
For Injection |
Intramuscular |
75IU |
Single-Dose Vial |
1994/09/01
|
Organon USA Inc., a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Humegon |
020328 |
002 |
351(a) |
menotropins |
For Injection |
Intramuscular |
150IU |
Single-Dose Vial |
1994/09/01
|
Organon USA Inc., a subsidiary of Merck & Co., Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Cerezyme |
020367 |
001 |
351(a) |
imiglucerase |
For Injection |
Intravenous |
200UNITS/VIAL |
Single-Dose Vial |
1994/05/23
|
Genzyme Corporation |
Disc |
Licensed |
N/A |
N/A |
| Humulin R U-500 |
018780 |
004 |
351(a) |
insulin human |
Injection |
Subcutaneous |
10,000UNITS/20ML (500UNITS/ML) |
Multi-Dose Vial |
1994/03/31
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Oncaspar |
103411 |
001 |
351(a) |
pegaspargase |
Injection |
Intravenous, Intramuscular |
3,750IU/5ML(750IU/ML) |
Single-Dose Vial |
1994/02/01
|
Servier Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Pulmozyme |
103532 |
001 |
351(a) |
dornase alfa |
Solution |
Inhalation |
2.5MG/2.5ML (1MG/ML) |
Ampule |
1993/12/30
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Trasylol |
020304 |
001 |
351(a) |
aprotinin |
Injection |
Intravenous |
1,000,000KIU/100ML (10,000KIU/ML) |
Single-Dose Vial |
1993/12/29
|
Bayer HealthCare Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Trasylol |
020304 |
002 |
351(a) |
aprotinin |
Injection |
Intravenous |
2,000,000KIU/200ML (10,000KIU/ML) |
Single-Dose Vial |
1993/12/29
|
Bayer HealthCare Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Nutropin |
020168 |
001 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
5MG |
Multi-Dose Vial |
1993/11/17
|
Genentech, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Nutropin |
020168 |
002 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
10MG |
Multi-Dose Vial |
1993/11/17
|
Genentech, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Betaseron |
103471 |
001 |
351(a) |
interferon beta-1b |
For Injection |
Subcutaneous |
0.3MG |
Single-Dose Vial |
1993/07/23
|
Bayer HealthCare Pharmaceuticals Inc. |
Rx |
Licensed |
N/A |
N/A |
| Bioclate (Armour), Recombinate |
103375 |
001 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Bioclate (Armour), Recombinate |
103375 |
002 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Bioclate (Armour), Recombinate |
103375 |
003 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Orthoclone OKT3 |
103463 |
001 |
351(a) |
muromonab-CD3 |
Injection |
Intravenous |
1MG/ML |
Ampule |
1992/09/14
|
Centocor Ortho Biotech Products, L.P. |
Disc |
Voluntarily Revoked |
N/A |
N/A |